#Sweeteners are utilized to enhance the palatability of medications The global sweeteners market is projected to reach USD 125.1 billion by 2028 from 107.2 billion in 2023 at a CAGR of 3.1% during the forecast period, 2023-2028, in terms of value. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186278129 In the pharmaceutical industry, sweeteners are utilized to enhance the palatability of medications, especially those in liquid or chewable forms. Paediatric medications often incorporate sweeteners to improve taste and increase patient compliance. Sucralose, aspartame, and saccharin are some of the examples of sweeteners employed in pharmaceutical formulations. The growing recognition of the role sweeteners play in enhancing consumer experience and compliance in personal care and pharmaceutical products is a key driver in the expanding sweeteners market. Read more: https://www.marketsandmarkets.com/Market-Reports/sweeteners-market-186278129.html North America is growing at a significant rate in the sweeteners market due to a confluence of factors driving demand and consumption patterns. The region's high prevalence of health-conscious consumers and their increasing awareness of the adverse effects of traditional sugars on health contribute significantly to the demand for sweeteners. With a robust food and beverage industry, North America is quick to adopt innovations in low-calorie and sugar-free alternatives, propelling the growth of the sweeteners market. The key players in this market include Cargill, Incorporated (US), ADM (US), International Flavors & Fragrances Inc. (US), Ingredion Incorporated (US), Tate & Lyle (UK), Associated British Foods (UK), Südzucker AG (Germany), and Ajinomoto Co., Inc. (Japan).